| Date |
Description |
Institution |
# Students |
| 3/2017 - Present |
Membership on Supervising Committee |
The University of Texas Health Science Center at San Antonio |
|
|
| 8/2016 - Present |
Pharmacological Principles in Physical Therapy |
The University of Texas Health Science Center |
60 students |
| Course Director - Student Enrollment: 60.
I have been requested by the Department of Physical Therapy, School of Health Professions, to direct the course and be the primary teaching faculty starting Fall 2016. I was previously a lecturer giving a 2-hr lecture for the course between 8/2012 to 8/2013. |
| 6/2016 - Present |
PHAR7002 |
|
|
| Course Director - The Clinical Practicum in Pharmacology is a formal elective course for graduate students in the Physiology and Pharmacology Discipline that provides students with focused first-hand exposure to therapeutics and clinical practice. The course incorporates case-based scenarios and a clinical experience in an area relevant to the student?s area of research. |
| 1/2015 - Present |
Pharmacology II |
The University of Texas Health Science Center |
45 students |
| Course Director - Course Director and primary course faculty. Student Enrollment: 45 |
| 7/2014 - Present |
Pharmacology I |
The University of Texas Health Science Center |
45 students |
| Course Director - Course Director and primary course faculty. Student Enrollment: 45 |
| 9/2012 - Present |
CIRC 5007 Fundamentals: Molecules to Medicine |
|
250 students |
| Student Enrollment: 250 |
| 1/2011 - Present |
PHR 390N-Integrated Basic and Applied Pharmacokinetics, University of Texas at Austin |
|
106 students |
| Student Enrollment: 106. The course previously has a different course number: PHR 371S |
| 9/2010 - Present |
PHR 665E-Pharmacotherapeutics I, University of Texas at Austin |
|
106 students |
| Student Enrollment: 106.
The course previously had different course numbers: PHA 665E, and PHR 565F prior to 2010, for which I have been teaching since 12/2009. |
| 8/2008 - Present |
Therapeutics |
The University of Texas Health Science Center |
9 students |
| Course Director - Student Enrollment: 9.
I became the course director in 1/2009. In 2015, I directed the integration of this course, with physiological components, into a new course called Integrated Physiology and Therapeutics for graduate students from Pharmacology and Physiology track for the Fall semester of 2015. This course is also part of the curriculum of the Joint Biomedical Engineering Joint Graduate Program at the University of Texas at San Antonio and UTHSCSA. |
| 1/2007 - Present |
Pharmacology |
The University of Texas Health Science Center |
100 students |
| Course Director - Student Enrollment: 100.
I became the course director for this dental pharmacology course in Fall 2006. Prior to 2007, this course has a different course number (PHAR 6006), for which I also taught from 1/2000 to 5/2006.
In 2015, I took the initiative to revise and coordinate the teaching of this course with Freshman Dental Physiology into a single integrated theme-based course that started in Spring 2016. |
| 8/2002 - Present |
PGS 381W/PHAR 6020-Molecular and Pharmacological Basis of Therapeutics, UTA and UTHSCSA |
|
5 students |
| Course Director - Student Enrollment: 5.
I designed and implemented this course (previous course number PHR 381W) in 2002 to educate students the emerging role of pharmacogenetics and pharmacogenomics in optimization of drug therapy. The course is also listed as an elective course (PHAR 6020) for UTHSCSA pharmacology graduate students. Over the years, I have introduced different components to the basic didactic lecture format, including laboratory sessions, student debates on controversial topics, student presentations, faculty-led discussion, and field trips to clinical laboratories. This course is also part of the curriculum offering of the Joint Ph.D. degree in Translational Science at UTHSCSA, University of Texas at Austin, and University of Texas at San Antonio. |
| 8/2000 - Present |
Clinical Pharmacology |
The University of Texas Health Science Center |
12 students |
| Student Enrollment: 12. |
| 8/1993 - Present |
Prin of Pharmacology I |
The University of Texas Health Science Center |
9 students |
| Student Enrollment: 9.
Between 1988 to 1992, I was also involved in teaching Advanced Pharmacology, which was the "predecessor" of Principles of Pharmacology. |
Abstract |
| Chapa I, J Hensler F Lam, L McManus, A Giuffrida, E Russell-McKenzie, AL DePass. Examining outcomes of the Voelcker Biomedical Research Academy (VBRA) for high school students; 2017 Mar. (Proceedings of Understanding Interventions That Broaden Participation in Science Careers).
|
| Macy B, Lam YWF, Lam A. Comparing the Pharmacokinetics of Rectally Administered Phenobarbital Tablets in Microenema Form versus Suppository; 2016 Jan. (Journal of Pain and Symptom Management; vol. 51, no. 2).
|
| Wang C, Lehman D, Lam Y, Kuhn J, Mahalingam D, Weitman S, Hernandez J, Lorenzo C, Downs J, Espinoza S, Ramirez A. Metformin reduces prostate cancer disparity in men with type 2 diabetes?; 2015 Jun. (Diabetes; vol. 64, no. S1).
|
| Frei CR, Geng S, Kuhn JG, Lam YW, Talbert RL, Koeller JM, Seltzer JK, Nunez Y, Rangel L, Reveles KR, Lee GC, Boyd NK, Villarreal SM. A proposal incubator for pharmacy faculty; 2014 Jan. (Proceeding of the Annual Meeting of the American Association of Colleges of Pharmacy).
|
Book Chapter |
| Lam YWF. Clinically Significant Drug Interactions With Psychopharmacological Agents: Antidepressants. In: Jann, MW, Penzak S, Cohen L (ed). Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents. 2016. p. 451-469.
|
| Cavallari L, Lam YWF. Pharmacogenetics. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM (Editors). Pharmacotherapy: A Pathophysiologic Approach, 10th edition. New York, New York: McGraw-Hill; 2016. |
| Cavallari L, Lam YWF. Pharmacogenetics. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM (Editors). Pharmacotherapy: A Pathophysiologic Approach, 9th edition. New York, NY: McGraw-Hill; 2014. |
| Lam YWF, Cavallari L. Principles of Pharmacogenomics: Pharmacokinetic, Pharmacodynamic, and Clinical Implications. In: Lam YWF, Cavallari L. Pharmacogenomics: Challenges and Opportunities in Therapeutic Implementation. 2013. p. 1-44.
|
| Lam YWF, Fukui N, Sugai T, Watanabe J, Watanabe Y, Suzuki Y, Someya T. Pharmacogenomics in Psychiatric Disorders. In: Lam YWF, Cavallari L. Pharmacogenomics: Challenges and Opportunities in Therapeutic Implementation. 2013. p. 191-223.
|
| Aquilante C, Lam YWF. Role of Pharmacogenomics in Other Diseases and Therapeutic Areas. In: Lam YWF, Cavallari L. Pharmacogenomics: Challenges and Opportunities in Therapeutic Implementation. 2013. p. 247-271.
|
| Lam YWF. Translating Academic Research to Therapeutic Potentials. In: Lam YWF, Cavallari L. Pharmacogenomics: Challenges and Opportunities in Therapeutic Implementation. 2013. p. 45-61.
|
Book/Monograph |
| Lam YWF, Cavallari L (editors). Pharmacogenomics: Challenges and Opportunities in Therapeutic Implementation 2013. |
Electronic/Web Publication |
| Lam YWF. Scientific challenges and implementation barriers to translation of pharmacogenomics in clinical practice 2013 Jan. 17 p. Available from: http://dx.doi.org/10.1155/2013/641089. PMCID: PMC 3603536 . |
Journal Article |
| Hermann R, Lam YWF, Spackman G. True Allergic Reaction to Amide Local Anesthetics such as Lidocaine is Confirmed by Immunologic Testing Texas Dental Journal 2016 Feb;133.
|
| Lam YF, Lam A, Macy B. Pharmacokinetics of Phenobarbital in Micro-enema Via Macy Catheter versus Suppository Journal of Pain and Symptom Management 2016 Jan;51:994-1001.
|
| Wang CP, Lehman D, Lam YWF, Kuhn J, Mahalingam D, Weitman S, Lorenzo C, Downs JD, Stuart EA, Hernandez J, Thompson IM, Ramirez AG
. Metformin for Reducing Racial/Ethnic Difference in Prostate Cancer Incidence for Men with Type 2 Diabetes Cancer Prevention Research 2016 Jan;9:779-787.
|
